Oberweis International Opportunities Fund

3333 WARRENVILLE ROAD,SUITE 500
LISLE , IL, 60532

Rank

Rank Universe

Summary

The fund seeks long-term capital appreciation by investing in small-cap companies outside the United States including emerging markets.

The fund operates on a belief that investors are slow in processing new information and this persistent lag in investor’s response in recognizing positive catalyst change leads to market inefficiency.

The investment process starts with a list of companies with market capitalization be More

Link

Directors

Mar 14, 2024
  • Katherine Smith Dedrick
  • Alix J. Charles
  • Michael J. Simon

Chief Compliance Officer

  • Thomas P. Joyce

Fund Manager(s)

Price

  • $ 18.98 ( -0.03 )
    Nov 1, 2024
    Last Close
  • Net Assets
  • $394M
    Feb 29, 2024
  • Holding
  • 29
    Aug 29, 2024
    More

  • 52-Week High/Low
  • $20.26 - $15.17
  • Turnover
  • 142%
  • Expense Ratio
  • 1.87%

Company Name

Holding

Santen Pharmaceutical Co Ltd 2.58 %
Accelleron Industries AG 2.33 %
Arcadis NV 2.19 %
Daiwa Securities Group Inc 2.18 %
Constellium SE 1.96 %
Ashtead Technology Holdings pl 1.88 %
Asics Corp 1.72 %
AAK AB 1.67 %
ABC-Mart Inc 1.66 %
Yamazaki Baking Co Ltd 1.64 %
More 1.64 %

Documents

Prospectus

Annual Reports

Performance

YTD

5.5%

3 Year

-43.14%

5 Year

0.48%

Best

62.22%

2020

Worst

-60.5%

2008

Alpha

OBIOX S&P 500

Chart +